646 results on '"Eyal, Nir"'
Search Results
2. Research during Pandemics and Epidemics
3. Ethical Issues in Disaster Medicine
4. Contributors
5. Broad cross-national public support for accelerated COVID-19 vaccine trial designs
6. Mass drug administration of azithromycin: an analysis
7. “Cure” Versus “Clinical Remission”: The Impact of a Medication Description on the Willingness of People Living with HIV to Take a Medication
8. Research during Pandemics and Epidemics
9. Risk to Nonparticipants in HIV Remission Studies With Treatment Interruption: A Symposium
10. Ethical issues in HIV remission trials
11. Why continuing uncertainties are no reason to postpone challenge trials for coronavirus vaccines
12. It’s ethical to test promising coronavirus vaccines against less-promising ones
13. “Thought provoking”, “interactive”, and “more like a peer talk”: Testing the deliberative interview style in Germany
14. Joint statement in support of hepatitis C human challenge studies
15. Why Challenge Trials of SARS-CoV-2 Vaccines Could Be Ethical Despite Risk of Severe Adverse Events
16. Electronic Adherence Monitoring May Facilitate Intentional HIV Status Disclosure Among People Living with HIV in Rural Southwestern Uganda
17. Adding Lithium to Drinking Water for Suicide Prevention—The Ethics
18. HIV Cure Research : Risks Patients Expressed Willingness to Accept
19. Prioritizing second-generation SARS-CoV-2 vaccines through low-dosage challenge studies
20. Testing SARS-CoV-2 vaccine efficacy through deliberate natural viral exposure
21. International AIDS Society global scientific strategy: towards an HIV cure 2016
22. AIDS Activism and Coronavirus Vaccine Challenge Trials
23. Progresar en los negocios y la vida: The BuDo Way
24. Risk to study nonparticipants : A procedural approach
25. The establishment of a microvascular free flap service in a medium-sized hospital (500 beds)—an eight-year experience
26. When offering a patient beneficial treatment undermines public health.
27. What can the lived experience of participating in risky HIV cure-related studies establish?
28. Inequality in Political Philosophy and in Epidemiology : A Remarriage
29. Invited Commentary on Dubé et al. (Perceptions of Equipoise, Risk/Benefit Ratios, and “Otherwise Healthy Volunteers” in the Context of Early-Phase HIV Cure Research in the United States—A Qualitative Inquiry) : Are HIV-Infected Candidates for Participation in Risky Cure-Related Studies Otherwise Healthy?
30. Can Rationing through INCONVENIENCE Be Ethical?
31. Introduction
32. Measuring Health-State Utility via Cured Patients
33. A new day for human challenge trials?
34. Vaccine testing for emerging infections: the case for individual randomisation
35. Ugandan Study Participants Experience Electronic Monitoring of Antiretroviral Therapy Adherence as Welcomed Pressure to Adhere
36. Overcoming HIV Stigma? A Qualitative Analysis of HIV Cure Research and Stigma Among Men Who Have Sex with Men Living with HIV
37. Escitalopram or novel herbal treatments differentially alter cytokine and behavioral responses to immune challenge
38. 11 - Ethical Issues in Disaster Medicine
39. Improving vaccine trials in infectious disease emergencies
40. Paying for antiretroviral adherence: is it unethical when the patient is an adolescent?
41. Afterword: returning to philosophical foundations in research ethics
42. The benefit/risk ratio challenge in clinical research, and the case of HIV cure: an introduction
43. How to keep high-risk studies ethical: classifying candidate solutions
44. The phantasm of zero suicide
45. All research that might result in a pandemic must undergo external review
46. Three Case Studies in Making Fair Choices on the Path to Universal Health Coverage
47. Incommensurability and Trade
48. Research ethics and public trust in vaccines: the case of COVID-19 challenge trials
49. "Non-consequentialist Utilitarianism"
50. Joint statement in support of hepatitis C human challenge studies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.